Compare SR & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SR | PRGO |
|---|---|---|
| Founded | 1857 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 1.8B |
| IPO Year | N/A | 1991 |
| Metric | SR | PRGO |
|---|---|---|
| Price | $83.03 | $13.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $87.00 | $22.00 |
| AVG Volume (30 Days) | 445.3K | ★ 4.8M |
| Earning Date | 02-04-2026 | 11-05-2025 |
| Dividend Yield | 3.80% | ★ 8.77% |
| EPS Growth | ★ 4.30 | N/A |
| EPS | ★ 4.37 | N/A |
| Revenue | $2,476,400,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | $13.96 | N/A |
| Revenue Next Year | $9.43 | N/A |
| P/E Ratio | $18.89 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $64.54 | $12.17 |
| 52 Week High | $91.11 | $30.93 |
| Indicator | SR | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 41.86 | 41.18 |
| Support Level | $82.01 | $12.74 |
| Resistance Level | $85.03 | $13.63 |
| Average True Range (ATR) | 1.44 | 0.46 |
| MACD | -0.02 | 0.24 |
| Stochastic Oscillator | 31.99 | 51.62 |
Spire Inc. is the holding company for Spire Missouri, Spire Alabama, other gas utilities, and gas-related businesses, focused on growing organically, investing in infrastructure, and advancing through innovation. Its three segments are Gas Utility, Gas Marketing, and Midstream. The Gas Utility segment is the core business and includes Spire Missouri, Spire Alabama, and Spire EnergySouth. The Gas Marketing segment includes Spire Marketing, which provides non-regulated natural gas services across the U.S. The Midstream segment includes Spire Storage, Spire STL Pipeline, and Spire MoGas Pipeline. The majority of revenue comes from Gas Utility.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.